Epoxide-mediated differential packaging of cif and other virulence factors into outer membrane vesicles

Journal of Bacteriology

Volumn 196, Issue 20, 2014, Pages 3633-3642

  Ballok, Alicia E ^a   Filkins, Laura M ^a   Bomberger, Jennifer M ^a   Stanton, Bruce A ^a   O'Toole, George A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIBIOTIC AGENT; BACTERIAL PROTEIN; EPOXIDE; OUTER MEMBRANE PROTEIN; PROTEIN CIF; UNCLASSIFIED DRUG; VIRULENCE FACTOR; CIF PROTEIN, PSEUDOMONAS AERUGINOSA; OPRF PROTEIN, PSEUDOMONAS AERUGINOSA; PHOSPHOLIPASE;

ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CELL DENSITY; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; HOST PATHOGEN INTERACTION; HYDROLYSIS; MEMBRANE VESICLE; NONHUMAN; OUTER MEMBRANE VESICLE; PACKAGING; PROTEIN CONTENT; PROTEOMICS; PSEUDOMONAS AERUGINOSA; SILVER STAINING; TRANSPOSON; WESTERN BLOTTING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PROTEIN TRANSPORT;

ALKALINE PHOSPHATASE; BACTERIAL PROTEINS; EPOXY COMPOUNDS; GENE EXPRESSION REGULATION, BACTERIAL; PHOSPHOLIPASES; PROTEIN TRANSPORT; PSEUDOMONAS AERUGINOSA; STRESS, PHYSIOLOGICAL; VIRULENCE FACTORS;

EID: 84907092909     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.01760-14     Document Type: Article

References (54)

1. Bleves S, Viarre V, Salacha R, Michel GP, Filloux A, Voulhoux R. 2010. Protein secretion systems in Pseudomonas aeruginosa: a wealth of pathogenic weapons. Int. J. Med. Microbiol. 300:534-543. http://dx.doi.org/10.1016/j.ijmm.2010.08.005.
2. Hauser AR. 2009. The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat. Rev. Microbiol. 7:654-665. http://dx.doi.org/10.1038/nrmicro2199.
3. Kadurugamuwa JL, Beveridge TJ. 1997. Natural release of virulence factors in membrane vesicles by Pseudomonas aeruginosa and the effect of aminoglycoside antibiotics on their release. J. Antimicrob. Chemother. 40:615-621. http://dx.doi.org/10.1093/jac/40.5.615.
4. Schwechheimer C, Sullivan CJ, Kuehn MJ. 2013. Envelope control of outer membrane vesicle production in Gram-negative bacteria. Biochemistry 52:3031-3040. http://dx.doi.org/10.1021/bi400164t.
5. Yonezawa H, Osaki T, Kurata S, Fukuda M, Kawakami H, Ochiai K, Hanawa T, Kamiya S. 2009. Outer membrane vesicles of Helicobacter pylori TK1402 are involved in biofilm formation. BMC Microbiol. 9:197. http://dx.doi.org/10.1186/1471-2180-9-197.
6. Bomberger JM, Maceachran DP, Coutermarsh BA, Ye S, O'Toole GA, Stanton BA. 2009. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 5:e1000382. http://dx.doi.org/10.1371/journal.ppat.1000382.
7. Manning AJ, Kuehn MJ. 2011. Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC Microbiol. 11:258. http://dx.doi.org/10.1186/1471-2180-11-258.
8. Yaron S, Kolling GL, Simon L, Matthews KR. 2000. Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria. Appl. Environ. Microbiol. 66:4414-4420. http://dx.doi.org/10.1128/AEM.66.10.4414-4420.2000.
9. Kulp A, Kuehn MJ. 2010. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol. 64:163-184. http://dx.doi.org/10.1146/annurev.micro.091208.073413.
10. Shen Y, Torchia ML, Lawson GW, Karp CL, Ashwell JD, Mazmanian SK. 2012. Outer membrane vesicles of a human commensal mediate immune regulation and disease protection. Cell Host Microbe 12:509-520. http://dx.doi.org/10.1016/j.chom.2012.08.004.
11. McBroom AJ, Johnson AP, Vemulapalli S, Kuehn MJ. 2006. Outer membrane vesicle production by Escherichia coli is independent of membrane instability. J. Bacteriol. 188:5385-5392. http://dx.doi.org/10.1128/JB.00498-06.
12. Kadurugamuwa JL, Clarke AJ, Beveridge TJ. 1993. Surface action of gentamicin on Pseudomonas aeruginosa. J. Bacteriol. 175:5798-5805.
13. Kobayashi H, Uematsu K, Hirayama H, Horikoshi K. 2000. Novel toluene elimination system in a toluene-tolerant microorganism. J. Bacteriol. 182:6451-6455. http://dx.doi.org/10.1128/JB.182.22.6451-6455.2000.
14. McBroom AJ, Kuehn MJ. 2007. Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol. Microbiol. 63:545-558. http://dx.doi.org/10.1111/j.1365-2958.2006.05522.x.
15. Macdonald IA, Kuehn MJ. 2013. Stress-induced outer membrane vesicle production by Pseudomonas aeruginosa. J. Bacteriol. 195:2971-2981. http://dx.doi.org/10.1128/JB.02267-12.
16. Kadurugamuwa JL, Beveridge TJ. 1995. Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 177:3998-4008.
17. Mashburn LM, Whiteley M. 2005. Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature 437:422-425. http://dx.doi.org/10.1038/nature03925.
18. Mashburn-Warren L, Howe J, Brandenburg K, Whiteley M. 2009. Structural requirements of the Pseudomonas quinolone signal for membrane vesicle stimulation. J. Bacteriol. 191:3411-3414. http://dx.doi.org/10.1128/JB.00052-09.
19. Wessel AK, Liew J, Kwon T, Marcotte EM, Whiteley M. 2013. Role of Pseudomonas aeruginosa peptidoglycan-associated outer membrane proteins in vesicle formation. J. Bacteriol. 195:213-219. http://dx.doi.org/10.1128/JB.01253-12.
20. Bauman SJ, Kuehn MJ. 2006. Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect. 8:2400-2408. http://dx.doi.org/10.1016/j.micinf.2006.05.001.
21. MacEachran DP, Ye S, Bomberger JM, Hogan DA, Swiatecka-Urban A, Stanton BA, O'Toole GA. 2007. The Pseudomonas aeruginosa secreted protein PA2934 decreases apical membrane expression of the cystic fibro-sis transmembrane conductance regulator. Infect. Immun. 75:3902-3912. http://dx.doi.org/10.1128/IAI.00338-07.
22. Bomberger JM, Ye S, MacEachran DP, Koeppen K, Barnaby RL, O'Toole GA, Stanton BA. 2011. A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. PLoS Pathog. 7:e1011325. http://dx.doi.org/10.1371/journal.ppat.1001325.
23. Ballok AE, O'Toole GA. 2013. Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung. J. Bacteriol. 195:4013-4019. http://dx.doi.org/10.1128/JB.00339-13.
24. Bomberger JM, Ely KH, Bangia N, Ye S, Green KA, Green WR, Enelow RI, Stanton BA. 2014. Pseudomonas aeruginosa Cif protein enhances the ubiquitination and proteasomal degradation of the transporter associated with antigen processing (TAP) and reduces major histocompatibility complex (MHC) class I antigen presentation. J. Biol. Chem. 289:152-162. http://dx.doi.org/10.1074/jbc.M113.459271.
25. MacEachran DP, Stanton BA, O'Toole GA. 2008. Cif is negatively regulated by the TetR family repressor CifR. Infect. Immun. 76:3197-3206. http://dx.doi.org/10.1128/IAI.00305-08.
26. Ballok AE, Bahl CD, Dolben EL, Lindsay AK, St Laurent JD, Hogan DA, Madden DR, O'Toole GA. 2012. Epoxide-mediated CifR repression of cif gene expression utilizes two binding sites in Pseudomonas aeruginosa. J. Bacteriol. 194:5315-5324. http://dx.doi.org/10.1128/JB.00984-12.
27. Revermann M, Mieth A, Popescu L, Paulke A, Wurglics M, Pellowska M, Fischer AS, Steri R, Maier TJ, Schermuly RT, Geisslinger G, Schubert-Zsilavecz M, Brandes RP, Steinhilber D. 2011. A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysm. Br. J. Pharmacol. 163:1721-1732. http://dx.doi.org/10.1111/j.1476-5381.2011.01321.x.
28. Panigrahy D, Kalish BT, Huang S, Bielenberg DR, Le HD, Yang J, Edin ML, Lee CR, Benny O, Mudge DK, Butterfield CE, Mammoto A, Mammoto T, Inceoglu B, Jenkins RL, Simpson MA, Akino T, Lih FB, Tomer KB, Ingber DE, Hammock BD, Falck JR, Manthati VL, Kaipainen A, D'Amore PA, Puder M, Zeldin DC, Kieran MW. 2013. Epoxyeicosanoids promote organ and tissue regeneration. Proc. Natl. Acad. Sci. U. S. A. 110:13528-13533. http://dx.doi.org/10.1073/pnas.1311565110.
29. Hayakawa M, Sugiyama S, Takamura T, Yokoo K, Iwata M, Suzuki K, Taki F, Takahashi S, Ozawa T. 1986. Neutrophils biosynthesize leukotoxin, 9, 10-epoxy-12-octadecenoate. Biochem. Biophys. Res. Commun. 137:424-430. http://dx.doi.org/10.1016/0006-291X(86)91227-1.
30. Gomez MI, Prince A. 2007. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. Curr. Opin. Pharmacol. 7:244-251. http://dx.doi.org/10.1016/j.coph.2006.12.005.
31. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, Ausubel FM. 1995. Common virulence factors for bacterial pathogenicity in plants and animals. Science 268:1899-1902. http://dx.doi.org/10.1126/science.7604262.
32. Liberati NT, Urbach JM, Miyata S, Lee DG, Drenkard E, Wu G, Villanueva J, Wei T, Ausubel FM. 2006. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc. Natl. Acad. Sci. U. S. A. 103:2833-2838. http://dx.doi.org/10.1073/pnas.0511100103.
33. Jensch T, Fricke B. 1997. Localization of alanyl aminopeptidase and leucyl aminopeptidase in cells of Pseudomonas aeruginosa by application of different methods for periplasm release. J. Basic Microbiol. 37:115-128. http://dx.doi.org/10.1002/jobm.3620370206.
34. Anthony FA, Merat DL, Cheung WY. 1986. A spectrofluorimetric assay of calmodulin-dependent protein phosphatase using 4-methylumbelliferyl phosphate. Anal. Biochem. 155:103-107. http://dx.doi.org/10.1016/0003-2697(86)90232-0.
35. Kurioka S, Matsuda M. 1976. Phospholipase C assay using pnitrophenylphosphoryl-choline together with sorbitol and its application to studying the metal and detergent requirement of the enzyme. Anal. Biochem. 75:281-289. http://dx.doi.org/10.1016/0003-2697(76)90078-6.
36. Caiazza NC, O'Toole GA. 2004. SadB is required for the transition from reversible to irreversible attachment during biofilm formation by Pseudomonas aeruginosa PA14. J. Bacteriol. 186:4476-4485. http://dx.doi.org/10.1128/JB.186.14.4476-4485.2004.
37. Kuchma SL, Ballok AE, Merritt JH, Hammond JH, Lu W, Raminowitz JD, O'Toole GA. 2010. c-di-GMP-mediated repression of swarming motility by Pseudomonas aeruginosa: the pilY1 gene and its impact on surfaceassociated behaviors. J. Bacteriol. 192:2950-2964. http://dx.doi.org/10.1128/JB.01642-09.
38. Fito-Boncompte L, Chapalain A, Bouffartigues E, Chaker H, Lesouhaitier O, Gicquel G, Bazire A, Madi A, Connil N, Veron W, Taupin L, Toussaint B, Cornelis P, Wei Q, Shioya K, Deziel E, Feuilloley MG, Orange N, Dufour A, Chevalier S. 2011. Full virulence of Pseudomonas aeruginosa requires OprF. Infect. Immun. 79:1176-1186. http://dx.doi.org/10.1128/IAI.00850-10.
39. Tashiro Y, Sakai R, Toyofuku M, Sawada I, Nakajima-Kambe T, Uchiyama H, Nomura N. 2009. Outer membrane machinery and alginate synthesis regulators control membrane vesicle production in Pseudomonas aeruginosa. J. Bacteriol. 191:7509-7519. http://dx.doi.org/10.1128/JB.00722-09.
40. Cahan R, Axelrad I, Safrin M, Ohman DE, Kessler E. 2001. A secreted aminopeptidase of Pseudomonas aeruginosa-identification, primary structure, and relationship to other aminopeptidases. J. Biol. Chem. 276:43645-43652. http://dx.doi.org/10.1074/jbc.M106950200.
41. Nunez C, Moreno S, Cardenas L, Soberon-Chavez G, Espin G. 2000. Inactivation of the ampDE operon increases transcription of algD and affects morphology and encystment of Azotobacter vinelandii. J. Bacteriol. 182:4829-4835. http://dx.doi.org/10.1128/JB.182.17.4829-4835.2000.
42. Bacik J-P, Whitworth GE, Stubbs KA, Yadav AK, Martin DR, Bailey-Elkin BA, Vocadlo DJ, Mark BL. 2011. Molecular basis of 1,6-anhydro bond cleavage and phosphoryl transfer by Pseudomonas aeruginosa 1,6-anhydro-N-acetylmuramic acid kinase. J. Biol. Chem. 286:12283-12291. http://dx.doi.org/10.1074/jbc.M110.198317.
43. Maredia R, Devineni N, Lentz P, Dallo SF, Yu J, Guentzel N, Chambers J, Arulanandam B, Haskins WE, Weitao T. 2012. Vesiculation from Pseudomonas aeruginosa under SOS. ScientificWorldJournal 2012:402919. http://dx.doi.org/10.1100/2012/402919.
44. Toyofuku M, Zhou S, Sawada I, Takaya N, Uchiyama H, Nomura N. 2013. Membrane vesicle formation is associated with pyocin production under denitrifying conditions in Pseudomonas aeruginosa PAO1. Environ. Microbiol. http://dx.doi.org/10.1111/1462-2920.12260.
45. Choi DS, Kim DK, Choi SJ, Lee J, Choi JP, Rho S, Park SH, Kim YK, Hwang D, Gho YS. 2011. Proteomic analysis of outer membrane vesicles derived from Pseudomonas aeruginosa. Proteomics 11:3424-3429. http://dx.doi.org/10.1002/pmic.201000212.
46. Hampton TH, Ballok AE, Bomberger JM, Rutkowski MR, Barnaby R, Coutermarsh B, Conejo-Garcia JR, O'Toole GA, Stanton BA. 2012. Does the F508-CFTR mutation induce a proinflammatory response in human airway epithelial cells? Am. J. Physiol. Lung Cell. Mol. Physiol. 303:L509-L518. http://dx.doi.org/10.1152/ajplung.00226.2011.
47. Haurat MF, Aduse-Opoku J, Rangarajan M, Dorobantu L, Gray MR, Curtis MA, Feldman MF. 2011. Selective sorting of cargo proteins into bacterial membrane vesicles. J. Biol. Chem. 286:1269-1276. http://dx.doi.org/10.1074/jbc.M110.185744.
48. Kato S, Kowashi Y, Demuth DR. 2002. Outer membrane-like vesicles secreted by Actinobacillus actinomycetemcomitans are enriched in leukotoxin. Microb. Pathog. 32:1-13. http://dx.doi.org/10.1006/mpat.2001.0474.
49. Horstman AL, Kuehn MJ. 2000. Enterotoxigenic Escherichia coli secretes active heat-labile enterotoxin via outer membrane vesicles. J. Biol. Chem. 275:12489-12496. http://dx.doi.org/10.1074/jbc.275.17.12489.
50. Schekman R, Orci L. 1996. Coat proteins and vesicle budding. Science 271:1526-1533. http://dx.doi.org/10.1126/science.271.5255.1526.
51. Venza I, Cucinotta M, Visalli M, De Grazia G, Oliva S, Teti D. 2009. Pseudomonas aeruginosa induces interleukin-8 (IL-8) gene expression in human conjunctiva through the recruitment of both RelA and CCAAT/Enhancer-binding protein beta to the IL-8 promoter. J. Biol. Chem. 284:4191-4199. http://dx.doi.org/10.1074/jbc.M805429200.
52. Bryant-Hudson KM, Carr DJJ. 2012. CXCL1-deficient mice are highly sensitive to Pseudomonas aeruginosa but not herpes simplex virus type 1 corneal infection. Invest. Ophthalmol. Vis. Sci. 53:6785-6792. http://dx.doi.org/10.1167/iovs.12-10400.
53. Kishimoto T, Akira S, Narazaki M, Taga T. 1995. Interleukin-6 family of cytokines and GP130. Blood 86:1243-1254.
54. Anderson GG, Moreau-Marquis S, Stanton BA, O'Toole GA. 2008. In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells. Infect. Immun. 76:1423-1433. http://dx.doi.org/10.1128/IAI.01373-07.